A single arm, open, single center phase II clinical study for Anlotinib plus Albumin taxol/Cisplatin in the treatment of recurrent or metastatic cervical cancer.
Latest Information Update: 02 Dec 2020
At a glance
- Drugs Catequentinib (Primary) ; Cisplatin; Paclitaxel
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 02 Dec 2020 New trial record